Skip to content
Drug recall · FDA · Published September 6, 2018

InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for:

Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size.

🇺🇸 FDA recall #D-1212-2018DrugInvaGen Pharmaceuticals, Inc. ›
Take action

Contact the company & request your remedy

Recalling firmInvaGen Pharmaceuticals, Inc.7 Oser Ave, N/A · Hauppauge, NY 11788-3811
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
Write-up in progress

We’re still writing up this recall

We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.

Source Page by GovInfoNow · govinfonow.com/recall/39656-invagen-pharmaceuticals-inc-recalls-bupropion-hydrochloride-er-tablets-usp-150 · Recall date September 6, 2018 · FDA enforcement record: FDA #D-1212-2018

Cite this page

“InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for:.” GovInfoNow, recall dated September 6, 2018. https://govinfonow.com/recall/39656-invagen-pharmaceuticals-inc-recalls-bupropion-hydrochloride-er-tablets-usp-150. Based on FDA recall #D-1212-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1212-2018%22&limit=1).

How to tell if you have this one

  • Brand
    InvaGen Pharmaceuticals, Inc.
  • Category
    Drug
Take action

Contact InvaGen Pharmaceuticals, Inc.

We’ve drafted a message you can send InvaGen Pharmaceuticals, Inc. to request your refund or repair — edit it as you like.

Subject: Recall D-1212-2018 — InvaGen Pharmaceuticals, Inc. InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tabl

Hello,

I own a InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for: that is covered by recall D-1212-2018 from InvaGen Pharmaceuticals, Inc..

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1212-2018 (September 6, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1212-2018 to see it in context.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA